Enanta Pharmaceuticals, Inc.;AbbVie Ireland Unlimited Company
发明人:
申请号：
EP14181565.4
公开号：
EP2805726B1
申请日:
2009.09.10
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention relates to novel macrocyclic compounds and methods of use thereof. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
